Robert M. Davis

Robert M. Davis, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Merck & Co., Inc. and Duke Energy Corp. Between 6 May 2021 and 29 April 2026, the trades on record add up to 16 filings.

The open-market record consists of 1 sale worth €1.5M, with no purchase. Besides market trades, the filings include 11 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 1 sale.

On 1 May 2026 came the latest disclosure, a share grant for €617k in Merck & Co., Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.